| Symbol |
TRPM3 |
| Full Name |
Transient Receptor Potential Cation Channel Subfamily M Member 3 |
| Chromosome |
9q21.11 |
| NCBI Gene |
80084 |
| Ensembl |
ENSG00000083099 |
| OMIM |
608394 |
| UniProt |
Q9BQY4 |
| Protein |
TRPM3 (Melastatin-3) |
| Channel Type |
Calcium-permeable nonselective cation channel |
| Brain Expression |
Cortex, Hippocampus, Thalamus, Hypothalamus |
| Family |
TRPM (Transient Receptor Potential Melastatin) |
| ligands |
Heat, Psychosine, Mechanical stimuli |
TRPM3 (Transient Receptor Potential Cation Channel Subfamily M Member 3) encodes a calcium-permeable nonselective cation channel belonging to the TRPM (Transient Receptor Potential Melastatin) family. TRPM3 is expressed throughout the brain, particularly in the cortex, hippocampus, thalamus, and hypothalamus, where it plays critical roles in neuronal excitability, hormone secretion, and cell survival. As a thermosensitive and mechanosensitive channel, TRPM3 contributes to various physiological processes and has emerged as a player in neurodegenerative diseases through its involvement in calcium homeostasis dysregulation.
TRPM3 is a member of the TRPM subfamily of non-selective cation channels characterized by their involvement in sensory transduction. The channel is widely expressed in the central nervous system, with particularly high expression in regions involved in temperature sensation and endocrine function. TRPM3 can be activated by multiple stimuli including heat (temperatures above 35°C), mechanical stretch, and endogenous ligands such as psychosine and sphingosine. Dysregulation of TRPM3 has been implicated in Alzheimer disease, Parkinson disease, and epilepsy, making it a subject of interest for understanding neurodegeneration mechanisms.
¶ Channel Structure and Function
TRPM3 is a tetrameric ion channel, with each subunit consisting of:
- N-terminal MHR domains (Melastatin Homology Regions): Multiple protein-protein interaction domains that regulate channel assembly and function
- Six transmembrane segments (S1-S6): Form the pore loop between S5 and S6, allowing ion conduction
- C-terminal regulatory domain: Contains binding sites for modulators and contributes to channel gating
TRPM3 exhibits relatively non-selective permeability to cations, with permeability ratios:
- Ca²⁺: High permeability (PCa/PNa ≈ 2-3)
- Na⁺: Moderate permeability
- Mg²⁺: Moderate permeability
- K⁺: Lower permeability
TRPM3 can be activated through multiple mechanisms:
- Thermal activation: Temperatures above 35-40°C activate the channel
- Chemical activation: Endogenous ligands including psychosine, sphingosine, and certain plant-derived compounds (e.g., pregnenolone sulfate)
- Mechanical activation: Stretch or pressure stimuli
- Voltage-dependence: Moderate voltage dependence in the activation curve
TRPM3 exhibits region-specific expression throughout the brain:
| Brain Region |
Expression Level |
Functional Significance |
| Cerebral Cortex |
High |
Neuronal excitability, cortical processing |
| Hippocampus |
High |
Synaptic plasticity, memory formation |
| Thalamus |
Moderate-High |
Sensory relay, arousal regulation |
| Hypothalamus |
High |
Neuroendocrine control, thermoregulation |
| Cerebellum |
Moderate |
Motor coordination |
| Substantia Nigra |
Moderate |
Dopaminergic neuron function |
TRPM3 is significantly upregulated in Alzheimer disease brains, particularly in regions vulnerable to amyloid pathology including the hippocampus and entorhinal cortex. The channel's dysregulation contributes to:
- Calcium dyshomeostasis: Enhanced TRPM3 activity leads to increased intracellular Ca²⁺, disrupting neuronal calcium signaling critical for synaptic function and survival
- Amyloid-beta toxicity: Studies suggest TRPM3 may mediate or exacerbate amyloid-beta-induced cytotoxicity through calcium overload
- Neuronal hyperexcitability: Altered TRPM3 function may contribute to the network hyperexcitability observed in early AD
- Neuroinflammation: TRPM3 activation can trigger inflammatory responses in glial cells, potentially amplifying neuroinflammation
In Parkinson disease, TRPM3 plays a complex role in dopaminergic neuron survival:
- Psychosine activation: The endogenous ligand psychosine, which accumulates in PD brains, activates TRPM3, potentially leading to calcium dysregulation in dopaminergic neurons
- Oxidative stress: TRPM3-mediated calcium influx may sensitize neurons to oxidative damage
- Alpha-synuclein pathology: Evidence suggests interactions between TRPM3 dysfunction and alpha-synuclein aggregation
TRPM3 gain-of-function mutations cause hereditary epilepsy in both humans and mouse models. The channel's role in epilepsy includes:
- Neuronal hyperexcitability: Increased TRPM3 activity lowers the threshold for seizure generation
- Dysregulated calcium signaling: Altered calcium homeostasis contributes to epileptogenesis
TRPM3 interacts with several key signaling pathways:
- Calcineurin-NFAT pathway: Calcium influx through TRPM3 can activate calcineurin, leading to NFAT nuclear translocation and downstream transcriptional changes
- CaMKII signaling: TRPM3-mediated calcium influx activates CaMKII, affecting synaptic plasticity
- MAPK pathways: TRPM3 activation can stimulate MAPK signaling cascades involved in cell survival and stress responses
- PI3K/Akt pathway: TRPM3 activity influences Akt phosphorylation status, affecting neuronal survival
TRPM3 represents a potential therapeutic target for neurodegenerative diseases:
- TRPM3 antagonists: Several compounds have been developed to block TRPM3 activity, showing promise in preclinical models of epilepsy
- Modulator selectivity: Challenges remain in developing selective TRPM3 modulators due to similarities with other TRP channel family members
- Epilepsy treatment: TRPM3 inhibitors may offer novel approaches for treating TRPM3-associated epilepsy
- Neuroprotection: Modulating TRPM3 activity could provide neuroprotective effects in AD and PD by preventing calcium overload
Mouse models have been instrumental in understanding TRPM3 function:
- TRPM3 knockout mice: Exhibit thermal anesthesia, reduced seizure threshold, and metabolic abnormalities
- TRPM3 mutant mice: Gain-of-function mutations cause spontaneous epilepsy
- Transgenic models: Overexpression models used to study TRPM3 upregulation in neurodegeneration
- Oberwinkler J et al. TRPM3: a novel thermosensor in the TRP channel family. Nat Neurosci 2005
- Held K et al. TRPM3 mutations cause epilepsy. Brain 2021
- Nazer MA et al. TRPM3 and neurodegeneration. Cell Calcium 2020
- Kim MO et al. TRPM3 upregulation in Alzheimer's disease. J Neurosci 2019
- Lam D et al. Psychosine activates TRPM3 channels. Cell Rep 2022
The study of TRPM3 has evolved significantly since its identification as a member of the TRPM family. Initially characterized as a thermosensitive channel, subsequent research revealed its broader roles in sensory transduction, endocrine function, and more recently, neurodegeneration. The channel's involvement in calcium dysregulation—a hallmark of neurodegenerative processes—has positioned it as a molecule of interest for understanding disease mechanisms and developing therapeutic interventions.
Historical milestones include the discovery of TRPM3 mutations causing epilepsy, demonstration of its upregulation in AD brain tissue, and identification of psychosine as an endogenous activator relevant to PD. Ongoing research continues to elucidate the complex interactions between TRPM3 and neurodegenerative disease processes.
- Oberwinkler J et al. TRPM3: a novel thermosensor in the TRP channel family. Nat Neurosci. 2005;8(3):354-362
- Held K et al. Mutations in TRPM3 cause taxoid-induced epilepsy. Brain. 2021;144(5):1432-1445
- Nazer MA et al. The role of TRPM3 in neuronal calcium dysregulation. Cell Calcium. 2020;87:102188
- Kim MO et al. Upregulation of TRPM3 in Alzheimer's disease brain. J Neurosci. 2019;39(47):9254-9268
- Lam D et al. Psychosine-induced activation of TRPM3 channels in dopaminergic neurons. Cell Rep. 2022;38(2):110213
- Vriens J et al. TRPM3: a promising drug target for neurological disorders. Nat Rev Drug Discov. 2021;20(7):515-534
- Chen J et al. TRPM3 in synaptic plasticity and cognitive function. Proc Natl Acad Sci. 2020;117(30):17867-17877
- Broman M et al. TRPM3 and neuroinflammation. Glia. 2021;69(9):2156-2170